GO:0052689 carboxylic ester hydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052689 carboxylic ester hydrolase activity is a molecular function defined as the catalysis of the hydrolysis of a carboxylic ester bond.
• Enzymes with this activity are widely distributed across species, from bacteria to humans, and include carboxylesterases, lipases, and esterases.
• Human pancreatic carboxylic ester hydrolase is identical to bile-salt-stimulated lipase and is important for lipid digestion.
• Carboxylesterases hydrolyze prodrugs such as capecitabine to active metabolites, influencing drug efficacy and toxicity.
• Serum carboxylic ester hydrolase is a sensitive marker for acute pancreatitis severity.
• Research on this activity uses activity assays, structural biology, and CRISPR-based gene editing to dissect gene function.
Description
Carboxylic ester hydrolase activity (GO:0052689) is a fundamental enzymatic function that catalyzes the cleavage of ester bonds in carboxylic esters, yielding an alcohol and a carboxylic acid. This activity is essential for the metabolism of lipids, xenobiotics, and prodrugs, and is found in organisms ranging from bacteria to humans. The term encompasses a large superfamily of enzymes, including carboxylesterases, lipases, and esterases, which share a common catalytic mechanism but differ in substrate specificity and physiological roles. Understanding this activity is crucial for drug metabolism, lipid digestion, and disease biomarker research. In humans, carboxylic ester hydrolases such as pancreatic carboxylic ester hydrolase (also known as bile-salt-stimulated lipase) play a key role in the intestinal digestion of dietary fats. Carboxylesterases in the liver and other tissues are involved in the hydrolysis of ester-containing drugs, affecting their pharmacokinetics and pharmacodynamics. Moreover, serum carboxylic ester hydrolase levels are elevated in acute pancreatitis, making it a potential diagnostic marker. Given its broad biological and clinical significance, carboxylic ester hydrolase activity is a subject of intense research. Advances in detection techniques, structural biology, and gene editing are providing new insights into the function and regulation of these enzymes. This article reviews the current knowledge of GO:0052689, covering its definition, mechanisms, key genes, disease associations, and research methodologies.
carboxylic ester hydrolase activity At A Glance
| GO ID | GO:0052689 |
|---|---|
| GO term | carboxylic ester hydrolase activity |
| Ontology | molecular_function |
| Synonym | carboxylate esterase activity, carboxylic esterase activity, hydrolase activity acting on ester bonds |
| Major function | Catalysis of the hydrolysis of a carboxylic ester bond |
| EC number | 3.1.1.- |
| Found in | Bacteria, archaea, eukaryotes, including humans |
| Representative enzymes | Carboxylesterases, lipases, esterases, bile-salt-stimulated lipase |
| Clinical relevance | Drug metabolism, pancreatitis biomarker, lipid digestion |
What Is GO:0052689?
According to the Gene Ontology, carboxylic ester hydrolase activity (GO:0052689) is defined as the catalysis of the hydrolysis of a carboxylic ester bond. This activity involves the cleavage of an ester bond (R-COO-R') in the presence of water, producing a carboxylic acid (R-COOH) and an alcohol (R'-OH). The term is synonymous with carboxylate esterase activity, carboxylic esterase activity, and hydrolase activity acting on ester bonds. It is classified as a molecular function and is carried out by a diverse group of enzymes known as carboxylic ester hydrolases, which include carboxylesterases, lipases, and esterases.
Why Is carboxylic ester hydrolase activity Important in Cell Biology?
Carboxylic ester hydrolase activity is critically important because it governs the breakdown of esters in diverse biological contexts, from dietary lipid digestion to the activation or detoxification of drugs and environmental chemicals. Dysregulation of these enzymes is associated with diseases such as pancreatitis, and their activity influences the efficacy of prodrugs like capecitabine. Furthermore, these enzymes are targets for drug design and are used as biomarkers for disease severity. Understanding their mechanism and regulation is essential for developing therapeutic interventions and for interpreting drug metabolism data.
• Essential for the digestion and absorption of dietary fats and lipids.
• Key role in the metabolism of ester-containing drugs and prodrugs, affecting drug efficacy and toxicity.
• Serum carboxylic ester hydrolase is a sensitive marker for acute pancreatitis severity.
• Involved in the detoxification of xenobiotics and environmental chemicals.
• Provides a model system for studying enzyme structure-function relationships and catalytic mechanisms.
• Bacterial carboxylic ester hydrolases contribute to pathogenesis and are potential antibiotic targets.
• Used in biotechnology for ester synthesis and hydrolysis in industrial processes.
• Genetic variations in carboxylesterases can lead to interindividual differences in drug response.
• Important for understanding lipid metabolism disorders and obesity.
• Facilitates the development of activity-based probes and inhibitors for research and therapy.
Mechanism, Genes and Research Methods of carboxylic ester hydrolase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs an ester molecule and breaks it apart using water.
Carboxylic ester hydrolases typically contain a catalytic triad (Ser-His-Asp/Glu) in their active site. The substrate, a carboxylic ester, binds to the enzyme, and the serine residue performs a nucleophilic attack on the carbonyl carbon, forming an acyl-enzyme intermediate. Water then hydrolyzes this intermediate, releasing the carboxylic acid and regenerating the free enzyme. The reaction is highly conserved across species, as seen in bacterial esterases like SeE from Streptococcus equi.
Structural Diversity and Classification
In simple terms: These enzymes come in many shapes but share a common core structure.
Carboxylic ester hydrolases are classified into several families based on their primary, secondary, and tertiary structures. The ESTHER database and other resources categorize them into blocks, such as the alpha/beta hydrolase fold family, which includes most carboxylesterases and lipases. Despite low sequence similarity, they share a common structural scaffold and catalytic mechanism. For example, human pancreatic carboxylic ester hydrolase is a serine esterase with a typical alpha/beta hydrolase fold.
Cofactors and Regulatory Elements
In simple terms: Some of these enzymes need help from other molecules to work properly.
Many carboxylic ester hydrolases require no cofactors, but some are activated by bile salts or other detergents. Human pancreatic carboxylic ester hydrolase (bile-salt-stimulated lipase) requires bile salts for optimal activity and binds to lipid interfaces. Other enzymes may be regulated by phosphorylation or glycosylation, although these modifications are less characterized. The activity can be inhibited by specific inhibitors such as loperamide, which inhibits carboxylesterase-mediated hydrolysis of capecitabine.
Tissue Distribution and Physiological Roles
In simple terms: These enzymes are found in many organs and do different jobs depending on where they are.
Carboxylic ester hydrolases are expressed in the liver, pancreas, intestine, and other tissues. Pancreatic carboxylic ester hydrolase is secreted into the duodenum, where it hydrolyzes dietary triglycerides and cholesterol esters. Hepatic carboxylesterases metabolize drugs and xenobiotics. In the serum, carboxylic ester hydrolase levels increase during acute pancreatitis, reflecting pancreatic damage. Bacterial esterases, such as SeE from Streptococcus equi, may contribute to host-pathogen interactions.
Key Genes Involved in GO:0052689 carboxylic ester hydrolase activity
The following genes encode enzymes with carboxylic ester hydrolase activity, each with distinct roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CES1 | Liver carboxylesterase 1; hydrolyzes ester drugs and endogenous lipids | Drug metabolism, prodrug activation, fatty acid ethyl ester synthase |
| CES2 | Intestinal carboxylesterase 2; activates prodrugs like irinotecan | Prodrug activation, drug resistance, cancer chemotherapy |
| CEL | Carboxyl ester lipase; pancreatic enzyme for lipid digestion | Pancreatitis, lipid metabolism, bile-salt-stimulated lipase |
| LIPF | Gastric lipase; hydrolyzes dietary triglycerides | Digestion, infant nutrition, lipid absorption |
| PNLIP | Pancreatic triacylglycerol lipase; main fat-digesting enzyme | Pancreatic insufficiency, lipid metabolism |
| LPL | Lipoprotein lipase; hydrolyzes triglycerides in lipoproteins | Hyperlipidemia, atherosclerosis, energy homeostasis |
| LIPE | Hormone-sensitive lipase; mobilizes stored fat | Lipolysis, obesity, diabetes |
| MGLL | Monoglyceride lipase; hydrolyzes monoglycerides | Endocannabinoid signaling, pain, inflammation |
| FAAH | Fatty acid amide hydrolase; degrades endocannabinoids | Pain, anxiety, neuropsychiatric disorders |
| ACHE | Acetylcholinesterase; hydrolyzes acetylcholine | Neurotransmission, Alzheimer's disease, insecticides |
| BCHE | Butyrylcholinesterase; hydrolyzes various esters | Drug metabolism, cocaine toxicity, Alzheimer's disease |
| PON1 | Paraoxonase 1; hydrolyzes organophosphates and lactones | Cardiovascular disease, pesticide detoxification |
| PON2 | Paraoxonase 2; intracellular lactonase | Oxidative stress, atherosclerosis, diabetes |
| PON3 | Paraoxonase 3; associated with HDL | Lipid metabolism, cardiovascular disease |
| EPHX1 | Microsomal epoxide hydrolase; hydrolyzes epoxides | Xenobiotic metabolism, cancer susceptibility |
| EPHX2 | Soluble epoxide hydrolase; hydrolyzes epoxyeicosatrienoic acids | Inflammation, hypertension, pain |
| ABHD6 | Alpha/beta hydrolase domain 6; hydrolyzes monoacylglycerol | Endocannabinoid system, obesity, epilepsy |
| ABHD12 | Alpha/beta hydrolase domain 12; hydrolyzes lysophosphatidylserine | Neurodegeneration, PHARC syndrome |
How Is carboxylic ester hydrolase activity Regulated?
The activity of carboxylic ester hydrolases is regulated at multiple levels. Transcriptional regulation controls enzyme abundance in response to dietary and hormonal signals. For example, pancreatic carboxylic ester hydrolase is secreted in response to food intake. Post-translational modifications, such as glycosylation, can affect enzyme stability and activity. Additionally, endogenous inhibitors and activators, such as bile salts, modulate activity in the digestive tract. In drug metabolism, competitive inhibition by co-administered drugs can alter carboxylesterase activity, as seen with loperamide inhibiting capecitabine hydrolysis. Hormonal regulation, such as insulin effects on lipases, also plays a role, though specific mechanisms for many family members remain to be fully elucidated.
carboxylic ester hydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CEL | Acute pancreatitis, lipid malabsorption | Cel knockout mouse, pancreatic acinar cell lines |
| CES1 | Drug metabolism variability, capecitabine toxicity | Ces1 knockout mouse, human hepatocyte models |
| CES2 | Irinotecan resistance, cancer chemotherapy | Ces2 knockout mouse, intestinal organoids |
| LPL | Familial chylomicronemia, atherosclerosis | Lpl knockout mouse, adipocyte-specific knockout |
| ACHE | Alzheimer's disease, myasthenia gravis | Ache knockout mouse, neuronal cell lines |
Acute Pancreatitis
Serum carboxylic ester hydrolase is a sensitive marker for acute pancreatitis and correlates with disease severity. In a guinea pig model of ischemic pancreatitis, carboxylic ester hydrolase levels increased significantly, suggesting its utility as a diagnostic and prognostic biomarker. Clinical studies have confirmed that serum carboxylic ester hydrolase is elevated in patients with acute pancreatitis and can indicate the severity of the disease. This enzyme is released from the pancreas during inflammation, making it a valuable tool for early detection and monitoring.
Drug Metabolism and Cancer Chemotherapy
Carboxylesterases, particularly CES1 and CES2, play critical roles in the metabolism of ester-containing drugs. For example, capecitabine, an oral prodrug used in cancer therapy, is hydrolyzed to its active metabolite 5'-deoxy-5-fluorocytidine by human carboxylesterases. This hydrolysis can be inhibited by loperamide, potentially affecting drug efficacy. Genetic polymorphisms in CES1 and CES2 can lead to interindividual variability in drug response and toxicity, making them important targets for personalized medicine.
Lipid Metabolism Disorders
Carboxylic ester hydrolases involved in lipid digestion, such as pancreatic carboxylic ester hydrolase and lipoprotein lipase, are linked to disorders of lipid metabolism. Deficiencies in these enzymes can lead to hypertriglyceridemia, atherosclerosis, and obesity. For instance, mutations in LPL cause familial chylomicronemia syndrome, characterized by severe hypertriglyceridemia. Understanding the regulation of these enzymes may provide therapeutic strategies for managing lipid disorders.
Neurodegenerative and Neurological Disorders
Several carboxylic ester hydrolases are critical for neurotransmitter metabolism and endocannabinoid signaling. Acetylcholinesterase (ACHE) hydrolyzes acetylcholine, and its inhibition is a mainstay of Alzheimer's disease therapy. Butyrylcholinesterase (BCHE) also contributes to acetylcholine hydrolysis and is a target for Alzheimer's treatment. Fatty acid amide hydrolase (FAAH) degrades endocannabinoids, and its inhibition has been explored for pain and anxiety. Mutations in ABHD12 cause PHARC syndrome, a neurodegenerative disorder.
From carboxylic ester hydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CES1 affect drug metabolism? | CES1 knockout mouse or human iPSC-derived hepatocytes |
| What is the role of CEL in lipid digestion? | CEL knockout mouse, pancreatic acinar cell lines |
| How do point mutations in LPL cause hypertriglyceridemia? | LPL point-mutation knock-in mouse |
| Can overexpression of CES2 enhance prodrug activation? | CES2 overexpression in cancer cell lines |
| What is the subcellular localization of ABHD12? | ABHD12 tagged knock-in in neuronal cells |
| Does inhibition of ACHE affect neurotransmission? | ACHE knockout or point-mutation models in neurons |
How to Study the carboxylic ester hydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Colorimetric esterase assay | Hydrolysis of p-nitrophenyl esters | Enzyme kinetics, inhibitor screening |
| Fluorometric assay | Hydrolysis of fluorogenic substrates | High-throughput screening |
| X-ray crystallography | Three-dimensional structure | Active site analysis, drug design |
| RNA-seq | Gene expression levels | Tissue-specific expression profiling |
| Western blot | Protein abundance | Validation of expression changes |
| Immunoassay | Serum enzyme levels | Pancreatitis biomarker detection |
| CRISPR knockout | Gene function loss | Target validation, disease modeling |
| CRISPR knock-in | Precise mutation introduction | Structure-function studies |
Enzyme Activity Assays
Carboxylic ester hydrolase activity is commonly measured using colorimetric or fluorometric substrates such as p-nitrophenyl esters or 4-methylumbelliferyl esters. These assays monitor the release of products (e.g., p-nitrophenol) spectrophotometrically or fluorometrically. Recent updates in detection techniques include the use of activity-based probes and mass spectrometry-based methods for high-throughput screening. Such assays are essential for characterizing enzyme kinetics, substrate specificity, and inhibitor efficacy.
Structural Biology
X-ray crystallography and cryo-electron microscopy have provided detailed insights into the three-dimensional structures of carboxylic ester hydrolases. These studies reveal the conserved alpha/beta hydrolase fold and catalytic triad. The ESTHER database classifies these enzymes based on structural features, aiding in functional prediction. Structural information is critical for rational drug design and understanding substrate binding.
Gene Expression and Proteomics
Transcriptomic and proteomic approaches are used to profile the expression of carboxylic ester hydrolases across tissues and conditions. Quantitative PCR, RNA-seq, and mass spectrometry can identify changes in enzyme levels in response to disease or drug treatment. For example, serum carboxylic ester hydrolase levels are measured by immunoassays in pancreatitis. These methods help link enzyme expression to physiological and pathological states.
CRISPR-Based Functional Genomics
CRISPR-Cas9 knockout, knock-in, and point-mutation models enable precise interrogation of gene function. For carboxylic ester hydrolases, knockout cell lines and animal models can reveal roles in drug metabolism, lipid digestion, and disease. Overexpression models can test gain-of-function effects. These approaches are complemented by CRISPR library screening to identify genes that modulate enzyme activity or drug response.
How CRISPR Can Be Used to Study GO:0052689 carboxylic ester hydrolase activity
Knockout
CRISPR-Cas9 knockout of carboxylic ester hydrolase genes (e.g., CES1, CES2, CEL) in cell lines or animal models allows researchers to study loss-of-function phenotypes. For example, CES1 knockout hepatocytes can reveal its role in drug metabolism. Knockout models are essential for validating gene function and identifying compensatory mechanisms.
Point Mutation
Introducing specific point mutations in the catalytic triad (e.g., serine to alanine) of carboxylic ester hydrolases can abolish enzymatic activity, providing insights into mechanism. Point mutations can also mimic naturally occurring polymorphisms associated with disease or altered drug response, such as in CES1 or LPL.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of carboxylic ester hydrolases enables visualization and purification of the enzyme. Knock-in of disease-associated mutations (e.g., in LPL or ABHD12) creates isogenic models to study pathogenesis and test therapeutics.
Overexpression
Overexpression of carboxylic ester hydrolases in cell lines (e.g., CES2 in cancer cells) can enhance prodrug activation or alter lipid metabolism. Overexpression models are useful for gain-of-function studies, drug screening, and biotechnological applications.
How EDITGENE Supports carboxylic ester hydrolase activity Research
Researchers studying carboxylic ester hydrolase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for carboxylic ester hydrolase activity research.
Frequently Asked Questions About carboxylic ester hydrolase activity
What is carboxylic ester hydrolase activity?
Carboxylic ester hydrolase activity (GO:0052689) is a molecular function that catalyzes the hydrolysis of a carboxylic ester bond, producing an alcohol and a carboxylic acid.
What genes are involved in carboxylic ester hydrolase activity?
Genes include CES1, CES2, CEL, LPL, ACHE, BCHE, and many others encoding carboxylesterases, lipases, and esterases.
What diseases are associated with carboxylic ester hydrolase activity?
Diseases include acute pancreatitis, lipid metabolism disorders, and neurodegenerative conditions like Alzheimer's disease.
How is carboxylic ester hydrolase activity measured?
It is measured using colorimetric or fluorometric substrates that release detectable products upon hydrolysis.
What is the role of carboxylesterases in drug metabolism?
Carboxylesterases hydrolyze ester-containing prodrugs like capecitabine to active metabolites, affecting drug efficacy and toxicity.
Is carboxylic ester hydrolase activity the same as lipase activity?
Lipases are a subset of carboxylic ester hydrolases that act on lipids; the term encompasses a broader range of esterases.
What is the catalytic mechanism of carboxylic ester hydrolases?
They typically use a serine-histidine-aspartate catalytic triad to form an acyl-enzyme intermediate, which is hydrolyzed by water.
Can carboxylic ester hydrolase activity be inhibited?
Yes, inhibitors such as loperamide can inhibit carboxylesterase-mediated hydrolysis of capecitabine.
What is the clinical significance of serum carboxylic ester hydrolase?
Elevated serum levels indicate acute pancreatitis and correlate with disease severity.
How can CRISPR be used to study carboxylic ester hydrolase activity?
CRISPR knockout, knock-in, and point mutation models allow precise manipulation of genes encoding these enzymes to study their function.
Conclusion
Carboxylic ester hydrolase activity (GO:0052689) is a fundamental enzymatic function with broad biological and clinical relevance. From lipid digestion to drug metabolism and disease biomarkers, these enzymes play critical roles in health and disease. Advances in detection techniques, structural biology, and CRISPR-based gene editing are driving new discoveries. Continued research on this activity will enhance our understanding of its regulation and facilitate the development of targeted therapies.
References
- 1. Chen Y et al.. 2016. Carboxylic ester hydrolases: Classification and database derived from their primary, secondary, and tertiary structures.. Protein Sci 25(11):1942-1953 PMID: 27530203
- 2. Lombardo D et al.. 1981. Binding of human pancreatic carboxylic ester hydrolase to lipid interfaces.. Biochim Biophys Acta 659(2):401-10 PMID: 7260101
- 3. Lan L et al.. 2020. Detection techniques of carboxylesterase activity: An update review.. Bioorg Chem 94:103388 PMID: 31676115
- 4. Xie G et al.. 2008. Esterase SeE of Streptococcus equi ssp. equi is a novel nonspecific carboxylic ester hydrolase.. FEMS Microbiol Lett 289(2):181-6 PMID: 19054107
- 5. Abouakil N et al.. 1988. Purification of pancreatic carboxylic-ester hydrolase by immunoaffinity and its application to the human bile-salt-stimulated lipase.. Biochim Biophys Acta 961(3):299-308 PMID: 3401497
- 6. Quinney SK et al.. 2005. Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide.. J Pharmacol Exp Ther 313(3):1011-6 PMID: 15687373
- 7. Blind PJ et al.. 1996. Carboxylic ester hydrolase and amylase in ischemic pancreatitis in the guinea pig.. Pancreas 12(4):388-95 PMID: 8740407
- 8. Blind PJ et al.. 1991. Carboxylic ester hydrolase. A sensitive serum marker and indicator of severity of acute pancreatitis.. Int J Pancreatol 8(1):65-73 PMID: 1709672
